Skip to content

Scientific publications

  • article Iorio-Duval C, Bélanger C, Vigneault É and Beaulieu L

    Retrospective evaluation of high-dose-rate brachytherapy multicriteria planning using physical dose versus radiobiological criteria for prostate cancer

    Sci Rep 16 (1), 2026.

    DOI PUBMED
  • article Poher A, Michaud G, Archambault L, Beaulieu L

    Polarized Cherenkov light imaging dosimetry: the impact of source to detector distance

    Phys Med Biol 71 (3), 2026.

    DOI PUBMED
  • article Akbari F, Peppa V, Ouellet S, Moghadam N, Oliver S, Gimenez-Alventosa V, Beaulieu L, Vijande J, Thomson RM

    Generation of 3D reference dosimetric datasets towards adoption of model-based dose calculations for permanent implant prostate brachytherapy

    Med Phys 53 (2), 2026.

    DOI PUBMED
  • article Sidibé I, Beaudry MM, Carignan D, Froment MA, Foster W, Bachand F, Vigneault E, Magnan S, Aubin S, Morrier J, Poulin E, Lacroix F, Lavallée MC, Beaulieu L, Martin AG

    Ultra-hypofractionated radiotherapy combined with HDR brachytherapy: An optimized treatment

    Radiother Oncol 214 2026.

    DOI PUBMED
  • article Ghannoudi C, Lavallée MC, Côté B, Beaulieu L

    Robust external-beam calibration of plastic scintillation detectors and uncertainty analysis for In-Vivo dosimetry in HDR brachytherapy

    Phys Med Biol 71 (7), 2026.

    DOI PUBMED
  • article Fabi F, Crook J, Jolicoeur M, Rauth S, Koll W, Tisseveransinghe S, Ebacher A, Niazi T, Duplan D, Bernard AA, Vavassis P, Foster W, Vigneault É and Archambault L, Beaulieu L, Lavallée MC, Lacroix F, Carignan D, Martin AG

    Pelvic nodes ultra-hypo fractionated versus conventionally fractionated IMRT with HDR brachytherapy in prostate cancer: interim analysis of a collaborative multi-institutional no…

    Radiother Oncol 221 2026.

    DOI PUBMED
  • article Lacroix F, Poulin E, Bélanger C, Aubin S, Carignan D, Vigneault E, Martin AG, Bachand F, Beaulieu L, Foster W

    A first-in-human randomized clinical trial of graphics processing units based multi-criteria optimization (gMCO) versus IPSA in high-dose-rate prostate brachytherapy

    Brachytherapy 25 (2), 2026.

    DOI PUBMED
  • article Beaulieu L, Bert C, Borot de Battisti M, Cormack RA, Cunha JAM, Damato AL, Deufel CL, Hautvast GLTF, Hsu IC, Kolkman-Deurloo IK, Moerland MA, Niatsetski Y, Weersink RA, Tanderup K

    AAPM task group 317 report: A joint AAPM and ESTRO report on brachytherapy catheter, needle, and applicator tracking technology

    Med Phys 52 (10), 2025.

    DOI PUBMED
  • article Mansour IR, Miksys N, Beaulieu L, Vigneault É and Thomson RM

    Haralick texture feature analysis for Monte Carlo dose distributions of permanent implant prostate brachytherapy

    Brachytherapy 24 (1), 2025.

    DOI PUBMED
  • article Koprivec D, Belanger C, Beaulieu L, Chatigny PY, Rosenfeld A, Cutajar D, Petasecca M, Howie A, Bucci J, Poder J

    Impact of robust optimization on patient specific error thresholds for high dose rate prostate brachytherapy source tracking

    Brachytherapy 24 (2), 2025.

    DOI PUBMED
  • article Chatigny PY, Bélanger C, Poulin É and Beaulieu L

    Automatic plan selection using deep network-A prostate study

    Med Phys 52 (3), 2025.

    DOI PUBMED
  • article Cervantes Y, Lambert-Girard S, Billas I, Therriault-Proulx F, Bouchard H, Archambault L, Beaulieu L

    A systematic characterization of plastic scintillation dosimeters response in magnetic fields: I. Experimental measurements

    Phys Med Biol 70 (10), 2025.

    DOI PUBMED